Symbols / SBFM $1.06 +1.92% Sunshine Biopharma, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NCM
SBFM Chart
About

Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Drug Manufacturers - Spe Market Cap 5.20M
Enterprise Value -3.34M Income -5.99M Sales 37.32M
Book/sh 5.31 Cash/sh 1.90 Dividend Yield —
Payout 0.00% Employees 52 IPO —
P/E 0.20 Forward P/E 0.01 PEG —
P/S 0.14 P/B 0.20 P/C —
EV/EBITDA 0.73 EV/Sales -0.09 Quick Ratio 2.02
Current Ratio 4.21 Debt/Eq 3.53 LT Debt/Eq —
EPS (ttm) 5.31 EPS next Y 199.80 EPS Growth —
Revenue Growth 11.60% Earnings 2026-04-03 11:00 ROA -9.87%
ROE -24.34% ROIC — Gross Margin 33.01%
Oper. Margin -5.65% Profit Margin -16.06% Shs Outstand 4.91M
Shs Float 4.90M Short Float 3.39% Short Ratio 4.38
Short Interest — 52W High 2.43 52W Low 1.00
Beta 1.60 Avg Volume 35.63K Volume 19.69K
Target Price $6.00 Recom None Prev Close $1.04
Price $1.06 Change 1.92%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.00
Mean price target
2. Current target
$1.16
Latest analyst target
3. DCF / Fair value
$-23.85
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.16
Low
$6.00
High
$6.00
Mean
$6.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-10-08 reit Aegis Capital Buy → Buy $7
2024-12-05 reit Aegis Capital Buy → Buy $15
2023-08-07 init Aegis Capital — → Buy $3
News
RSS: Latest SBFM news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
34.87
+44.75%
24.09
+454.42%
4.35
+1802.41%
0.23
Operating Revenue
34.87
+44.75%
24.09
+454.42%
4.35
+1802.41%
0.23
Cost Of Revenue
24.20
+53.64%
15.75
+494.69%
2.65
+2148.18%
0.12
Reconciled Cost Of Revenue
24.20
+53.64%
15.75
+494.69%
2.65
+2148.18%
0.12
Gross Profit
10.67
+27.95%
8.34
+391.53%
1.70
+1434.03%
0.11
Operating Expense
16.48
+25.58%
13.12
+26.55%
10.37
+306.57%
2.55
Research And Development
0.93
-49.68%
1.86
+128.59%
0.81
+20.77%
0.67
Selling General And Administration
14.94
+37.93%
10.83
+14.26%
9.48
+408.01%
1.87
Selling And Marketing Expense
0.94
+28.06%
0.73
+27.01%
0.58
0.00
General And Administrative Expense
14.00
+38.65%
10.10
+13.43%
8.90
+377.03%
1.87
Salaries And Wages
8.12
+32.81%
6.11
-3.81%
6.35
+422.91%
1.22
Other Gand A
5.88
+47.61%
3.98
+56.47%
2.55
+291.30%
0.65
Total Expenses
40.69
+40.89%
28.88
+121.80%
13.02
+387.89%
2.67
Operating Income
-5.81
-21.46%
-4.79
+44.83%
-8.67
-255.47%
-2.44
Total Operating Income As Reported
-5.81
-21.46%
-4.79
+82.28%
-27.00
-1006.53%
-2.44
EBITDA
-5.14
-34.31%
-3.82
+85.54%
-26.45
-118.66%
-12.09
Normalized EBITDA
-5.09
-33.17%
-3.82
+52.96%
-8.13
-234.94%
-2.43
Reconciled Depreciation
0.22
+49.87%
0.15
+492.72%
0.03
+97.50%
0.01
EBIT
-5.36
-34.90%
-3.97
+84.99%
-26.47
-118.64%
-12.11
Total Unusual Items
-0.04
-17892.65%
-0.00
+100.00%
-18.32
-89.46%
-9.67
Total Unusual Items Excluding Goodwill
-0.04
-17892.65%
-0.00
+100.00%
-18.32
-89.46%
-9.67
Special Income Charges
—
0.00
+100.00%
-18.32
-89.46%
-9.67
Other Special Charges
—
—
-0.01
-100.11%
9.67
Impairment Of Capital Assets
—
0.00
-100.00%
18.33
0.00
Net Income
-5.13
-13.94%
-4.51
+83.15%
-26.74
-115.05%
-12.44
Pretax Income
-5.37
-30.60%
-4.11
+84.49%
-26.51
-113.17%
-12.44
Net Non Operating Interest Income Expense
0.49
-27.78%
0.67
+40.78%
0.48
+245.75%
-0.33
Interest Expense Non Operating
0.01
-93.61%
0.14
+248.39%
0.04
-88.01%
0.33
Net Interest Income
0.49
-27.78%
0.67
+40.78%
0.48
+245.75%
-0.33
Interest Expense
0.01
-93.61%
0.14
+248.39%
0.04
-88.01%
0.33
Interest Income Non Operating
0.50
-38.91%
0.81
+56.56%
0.52
0.00
Interest Income
0.50
-38.91%
0.81
+56.56%
0.52
0.00
Other Income Expense
-0.04
-17892.65%
-0.00
+100.00%
-18.32
-89.46%
-9.67
Gain On Sale Of Security
-0.04
-17892.65%
-0.00
+48.53%
-0.00
-1052.00%
0.00
Tax Provision
-0.23
-159.43%
0.40
+69.38%
0.23
0.00
Tax Rate For Calcs
0.00
-79.05%
0.00
+0.00%
0.00
0.00
Tax Effect Of Unusual Items
-0.00
-3669.89%
-0.00
+100.00%
-3.85
0.00
Net Income Including Noncontrolling Interests
-5.13
-13.94%
-4.51
+83.15%
-26.74
-115.05%
-12.44
Net Income From Continuing Operation Net Minority Interest
-5.13
-13.94%
-4.51
+83.15%
-26.74
-115.05%
-12.44
Net Income From Continuing And Discontinued Operation
-5.13
-13.94%
-4.51
+83.15%
-26.74
-115.05%
-12.44
Net Income Continuous Operations
-5.13
-13.94%
-4.51
+83.15%
-26.74
-115.05%
-12.44
Normalized Income
-5.09
-13.01%
-4.51
+63.29%
-12.27
-343.29%
-2.77
Net Income Common Stockholders
-5.13
-13.94%
-4.51
+83.15%
-26.74
-115.05%
-12.44
Diluted EPS
-7.32
+97.92%
-351.36
+90.02%
-3,520.00
+63.03%
-9,520.00
Basic EPS
-7.32
+97.92%
-351.36
+90.02%
-3,520.00
+63.03%
-9,520.00
Basic Average Shares
0.70
+5371.73%
0.01
+68.97%
0.01
+481.16%
0.00
Diluted Average Shares
0.70
+5371.73%
0.01
+68.97%
0.01
+481.16%
0.00
Diluted NI Availto Com Stockholders
-5.13
-13.94%
-4.51
+83.15%
-26.74
-115.05%
-12.44
Depreciation Amortization Depletion Income Statement
0.22
+49.87%
0.15
+492.72%
0.03
+97.50%
0.01
Depreciation And Amortization In Income Statement
0.22
+49.87%
0.15
+492.72%
0.03
+97.50%
0.01
Depreciation Income Statement
—
—
—
0.01
Other Taxes
0.39
+33.57%
0.29
+424.57%
0.06
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
30.56
+11.75%
27.35
-6.49%
29.24
+1227.52%
2.20
Current Assets
25.97
+4.32%
24.89
-8.87%
27.31
+1143.83%
2.20
Cash Cash Equivalents And Short Term Investments
9.69
-40.55%
16.29
-25.35%
21.83
+967.22%
2.05
Cash And Cash Equivalents
9.69
-40.55%
16.29
-25.35%
21.83
+967.22%
2.05
Cash Financial
9.69
-40.55%
16.29
-25.35%
21.83
+967.22%
2.05
Receivables
3.87
+51.56%
2.55
+33.48%
1.91
+24421.07%
0.01
Accounts Receivable
3.87
+51.56%
2.55
+33.48%
1.91
+24421.07%
0.01
Inventory
11.28
+96.66%
5.73
+74.31%
3.29
+3014.00%
0.11
Finished Goods
11.28
+96.66%
5.73
—
—
Prepaid Assets
1.13
+264.88%
0.31
+9.44%
0.28
+662.59%
0.04
Total Non Current Assets
4.59
+86.98%
2.46
+27.20%
1.93
+27254.68%
0.01
Net PPE
1.48
+46.36%
1.01
-12.30%
1.15
+16252.61%
0.01
Gross PPE
1.82
+51.22%
1.20
-2.89%
1.24
+17439.50%
0.01
Accumulated Depreciation
-0.34
-77.13%
-0.19
-126.71%
-0.08
-30.91%
-0.06
Properties
0.00
0.00
0.00
—
Buildings And Improvements
0.94
+44.72%
0.65
—
—
Machinery Furniture Equipment
0.46
+24.86%
0.37
+16.11%
0.32
+4368.50%
0.01
Other Properties
0.34
+96.02%
0.17
-81.38%
0.92
+12971.00%
0.01
Leases
0.09
+399.92%
0.02
0.00
—
Goodwill And Other Intangible Assets
3.02
+109.08%
1.44
+85.91%
0.78
0.00
Non Current Deferred Assets
0.09
0.00
—
—
Non Current Deferred Taxes Assets
0.09
0.00
—
—
Total Liabilities Net Minority Interest
7.06
+14.99%
6.14
-19.39%
7.62
+282.49%
1.99
Current Liabilities
6.31
+13.74%
5.55
-19.90%
6.93
+7497.38%
0.09
Payables And Accrued Expenses
6.11
+12.41%
5.43
-20.19%
6.81
+7362.53%
0.09
Payables
6.11
+12.41%
5.43
-20.19%
6.81
+15753.91%
0.04
Accounts Payable
5.54
+114.39%
2.59
-7.75%
2.80
+6426.94%
0.04
Other Payable
0.30
-88.39%
2.55
-29.85%
3.63
—
Current Accrued Expenses
—
—
0.00
-100.00%
0.05
Total Tax Payable
0.27
-10.54%
0.30
-19.65%
0.37
0.00
Income Tax Payable
0.27
-10.54%
0.30
-19.65%
0.37
0.00
Current Debt And Capital Lease Obligation
0.21
+75.07%
0.12
-3.54%
0.12
—
Current Debt
—
—
3.63
—
Other Current Borrowings
—
—
3.63
—
Current Capital Lease Obligation
0.21
+75.07%
0.12
-3.54%
0.12
0.00
Other Current Liabilities
—
—
0.12
—
Total Non Current Liabilities Net Minority Interest
0.74
+26.70%
0.59
-14.23%
0.69
-63.93%
1.90
Long Term Debt And Capital Lease Obligation
0.74
+38.16%
0.54
-16.07%
0.64
-66.20%
1.90
Long Term Debt
—
—
—
1.90
Long Term Capital Lease Obligation
0.74
+38.16%
0.54
-16.07%
0.64
0.00
Non Current Deferred Liabilities
0.00
-100.00%
0.05
+13.24%
0.04
0.00
Non Current Deferred Taxes Liabilities
0.00
-100.00%
0.05
+13.24%
0.04
0.00
Stockholders Equity
23.50
+10.81%
21.21
-1.94%
21.63
+10117.97%
0.21
Common Stock Equity
23.49
+10.76%
21.21
-1.94%
21.63
+19267.89%
0.11
Capital Stock
0.02
+1436.49%
0.00
-95.70%
0.02
-77.01%
0.10
Common Stock
0.00
+18328.57%
0.00
-99.94%
0.02
+771.67%
0.00
Preferred Stock
0.01
+1200.00%
0.00
+0.00%
0.00
-99.00%
0.10
Share Issued
2.58
+18313.49%
0.01
+24.09%
0.01
+771.97%
0.00
Ordinary Shares Number
2.58
+18313.49%
0.01
+24.09%
0.01
+771.97%
0.00
Additional Paid In Capital
93.35
+10.59%
84.42
+4.42%
80.84
+146.56%
32.79
Retained Earnings
-69.04
-8.03%
-63.91
-7.59%
-59.40
-81.90%
-32.66
Gains Losses Not Affecting Retained Earnings
-0.83
-219.23%
0.70
+330.10%
0.16
+799.46%
-0.02
Other Equity Adjustments
-0.83
-219.23%
0.70
+330.10%
0.16
+799.46%
-0.02
Total Equity Gross Minority Interest
23.50
+10.81%
21.21
-1.94%
21.63
+10117.97%
0.21
Total Capitalization
23.50
+10.81%
21.21
-1.94%
21.63
+924.20%
2.11
Working Capital
19.65
+1.62%
19.34
-5.12%
20.38
+868.42%
2.10
Invested Capital
23.49
+10.76%
21.21
-1.94%
21.63
+975.06%
2.01
Total Debt
0.95
+44.82%
0.66
-14.05%
0.77
-59.72%
1.90
Capital Lease Obligations
0.95
+44.82%
0.66
-14.05%
0.77
0.00
Net Tangible Assets
20.48
+3.63%
19.76
-5.22%
20.85
+9750.95%
0.21
Tangible Book Value
20.47
+3.57%
19.76
-5.22%
20.85
+18572.17%
0.11
Current Notes Payable
—
—
—
0.00
Interest Payable
—
—
0.00
-100.00%
0.05
Preferred Stock Equity
0.01
+1200.00%
0.00
+0.00%
0.00
-99.00%
0.10
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-12.53
-42.80%
-8.78
-67.20%
-5.25
-186.93%
-1.83
Cash Flow From Continuing Operating Activities
-12.53
-42.80%
-8.78
-67.20%
-5.25
-186.93%
-1.83
Net Income From Continuing Operations
-5.13
-13.94%
-4.51
+83.15%
-26.74
-115.05%
-12.44
Depreciation Amortization Depletion
0.22
+49.87%
0.15
+492.72%
0.03
+97.50%
0.01
Depreciation
0.15
+32.35%
0.11
—
—
Amortization Cash Flow
0.08
+100.30%
0.04
—
—
Depreciation And Amortization
0.22
+49.87%
0.15
+492.72%
0.03
+97.50%
0.01
Amortization Of Intangibles
0.08
+100.30%
0.04
—
—
Other Non Cash Items
-2.24
—
-0.01
-101.11%
0.98
Asset Impairment Charge
—
0.00
-100.00%
18.33
0.00
Deferred Tax
0.00
0.00
—
—
Deferred Income Tax
0.00
0.00
—
—
Operating Gains Losses
—
—
0.00
-99.99%
9.73
Net Foreign Currency Exchange Gain Loss
—
0.00
-100.00%
0.00
+1196.00%
-0.00
Change In Working Capital
-5.38
-21.78%
-4.42
-240.06%
3.15
+2999.44%
-0.11
Change In Receivables
-2.34
-293.54%
-0.59
-13.28%
-0.52
-8816.80%
-0.01
Changes In Account Receivables
-2.34
-293.54%
-0.59
-13.28%
-0.52
-8816.80%
-0.01
Change In Inventory
-6.01
-153.93%
-2.37
-5603.45%
0.04
+152.50%
-0.08
Change In Prepaid Assets
-0.21
-879.84%
-0.02
-125.52%
0.08
+408.59%
-0.03
Change In Payables And Accrued Expense
3.17
+320.66%
-1.44
-140.45%
3.55
+61045.43%
0.01
Change In Accrued Expense
—
0.00
+100.00%
-0.05
-301.47%
0.02
Change In Payable
3.17
+320.66%
-1.44
-139.91%
3.60
+19936.13%
-0.02
Change In Account Payable
3.98
+392.04%
-1.36
-140.61%
3.36
+18601.55%
-0.02
Investing Cash Flow
-2.32
-253.71%
-0.66
+95.51%
-14.62
0.00
Cash Flow From Continuing Investing Activities
-2.32
-253.71%
-0.66
+95.51%
-14.62
0.00
Cash From Discontinued Investing Activities
—
—
—
0.00
Net PPE Purchase And Sale
-2.00
-4121.47%
0.05
+130.94%
-0.16
0.00
Purchase Of PPE
-2.00
-2329.87%
-0.08
+57.60%
-0.19
0.00
Sale Of PPE
—
0.13
+295.31%
0.03
0.00
Capital Expenditure
-2.32
-194.49%
-0.79
-158.40%
-0.30
—
Net Business Purchase And Sale
—
0.00
+100.00%
-14.35
0.00
Purchase Of Business
—
0.00
+100.00%
-14.35
0.00
Net Intangibles Purchase And Sale
-0.32
+54.34%
-0.71
-535.81%
-0.11
0.00
Purchase Of Intangibles
-0.32
+54.34%
-0.71
-535.81%
-0.11
0.00
Financing Cash Flow
9.29
+171.18%
3.43
-91.32%
39.47
+1258.68%
2.90
Cash Flow From Continuing Financing Activities
9.29
+171.18%
3.43
-91.32%
39.47
+1258.68%
2.90
Net Issuance Payments Of Debt
0.35
+376.16%
-0.13
+93.48%
-1.93
-166.51%
2.90
Issuance Of Debt
—
—
0.00
-100.00%
3.38
Repayment Of Debt
—
0.00
+100.00%
-1.90
-299.73%
-0.48
Long Term Debt Issuance
—
—
0.00
-100.00%
3.38
Long Term Debt Payments
—
0.00
+100.00%
-1.90
-299.73%
-0.48
Net Long Term Debt Issuance
0.35
+376.16%
-0.13
+93.48%
-1.93
-166.51%
2.90
Net Common Stock Issuance
5.38
+51.71%
3.55
-88.28%
30.27
0.00
Common Stock Payments
-3.14
-480.19%
-0.54
-446.61%
-0.10
—
Repurchase Of Capital Stock
-3.14
-480.19%
-0.54
-446.61%
-0.10
0.00
Proceeds From Stock Option Exercised
3.56
+101522.27%
0.00
-99.97%
13.19
0.00
Net Other Financing Charges
—
—
-2.06
—
Changes In Cash
-5.56
+7.38%
-6.01
-130.65%
19.60
+1722.08%
1.08
Effect Of Exchange Rate Changes
-1.04
-321.23%
0.47
+156.42%
0.18
+1007.40%
-0.02
Beginning Cash Position
16.29
-25.35%
21.83
+967.22%
2.05
+106.61%
0.99
End Cash Position
9.69
-40.55%
16.29
-25.35%
21.83
+967.22%
2.05
Free Cash Flow
-14.85
-55.30%
-9.56
-72.21%
-5.55
-203.61%
-1.83
Interest Paid Supplemental Data
0.01
0.00
-100.00%
0.05
+26.68%
0.04
Income Tax Paid Supplemental Data
0.58
0.00
0.00
0.00
Change In Income Tax Payable
-0.81
-1008.69%
-0.07
-130.23%
0.24
0.00
Change In Interest Payable
—
0.00
+100.00%
-0.05
-301.47%
0.02
Change In Tax Payable
-0.81
-1008.69%
-0.07
-130.23%
0.24
0.00
Common Stock Issuance
8.52
+108.41%
4.09
-86.53%
30.37
0.00
Issuance Of Capital Stock
8.52
+108.41%
4.09
-86.53%
30.37
0.00
Net Preferred Stock Issuance
—
—
-0.10
0.00
Preferred Stock Payments
—
—
-0.10
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category